Cart
sales@molnova.com
Cobalt chloride
CAS No. 7646-79-9
Cobalt chloride( —— )
Catalog No. M19444 CAS No. 7646-79-9
Cobalt(II) chloride is an anhydrous cobalt salt. Cobalt(II) chloride participates in the synthesis of various esters in the presence of acetonitrile.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCobalt chloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCobalt(II) chloride is an anhydrous cobalt salt. Cobalt(II) chloride participates in the synthesis of various esters in the presence of acetonitrile.
-
DescriptionCobalt(II) chloride is an anhydrous cobalt salt. Cobalt(II) chloride participates in the synthesis of various esters in the presence of acetonitrile.Cobalt(II) chloride catalyzes cross coupling of aryl halides or vinyl halides with aryl grignard reagents in excellent yields.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers
-
IndicationAnalytical reagent and ammonia absorber
Chemical Information
-
CAS Number7646-79-9
-
Formula Weight129.83
-
Molecular FormulaCoCl2
-
Purity>98% (HPLC)
-
SolubilityEthanol:Soluble;Water:Soluble
-
SMILESCl[Co]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Holstein Hetal.Human metabolism of orally administered radioactive cobalt chloride.J Environ Radioact. 2015 May;143:152-158.
molnova catalog
related products
-
HJ Inhibitor Peptide...
HJ Inhibitor Peptide 2
-
YX-2-107
YX-2-107 is a selective and potent CDK6-degrading PROTAC with an IC50 value of 4.4 nM.YX-2-107 inhibits RB phosphorylation and FOXM1 expression in vitro, and inhibits the development of Ph+ ALL in rats.
-
SARM1-IN-2
SARM1-IN-2 is a potent SARM1 inhibitor for the study of metabolic and neurological related diseases.
